CO
CONTIPRO AS
Grant-FundedCORDISNose-to-Brain Delivery of Biopharmaceutics for the therapy of central nervous system diseases: A design-based approach for efficient drug delivery systems
Biotech
CONTIPRO AS is a private SME recorded in CORDIS in Czech Republic, with participation in 7 EU research and innovation projects. Its recorded projects include “Nose-to-Brain Delivery of Biopharmaceutics for the therapy of central nervous system diseases: A design-based approach for efficient drug delivery systems”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
EU Grants€2,240,173
All-time revenue—
MRRPrivate••••••
Founder—
Founded—
🇨🇿Czech Republic
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics
Startup insights
Value proposition
CONTIPRO AS is a private SME recorded in CORDIS in Czech Republic, with participation in 7 EU research and innovation projects. Its recorded projects include “Nose-to-Brain Delivery of Biopharmaceutics for the therapy of central nervous system diseases: A design-based approach for efficient drug delivery systems”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
Biotech
Tags:Biotech
Company Info
CONTIPRO AS Info
Funding
EU Grants€2,240,173